Annual Results Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
1,901.98
1,243.34
933.01
701.89
540.10
380.83
301.03
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,901.98
1,243.34
933.01
701.89
540.10
380.83
301.03
Raw Material Cost
356.82
194.74
181.85
135.07
90.29
57.44
35.06
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
238.33
269.71
209.68
165.92
148.82
277.64
173.97
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
18.39
22.01
53.25
63.52
59.95
30.67
33.71
Selling and Distribution Expenses
548.60
472.04
441.98
272.64
309.68
284.81
209.98
Other Expenses
52.18
55.27
57.65
51.39
49.54
25.24
19.03
Total Expenditure (Excl Depreciation)
1,683.90
1,511.16
1,463.21
1,151.10
1,104.16
902.96
642.98
Operating Profit (PBDIT) excl Other Income
218.1
-267.8
-530.2
-449.20000000000005
-564.0999999999999
-522.1
-342
Other Income
68.92
188.59
20.80
101.58
116.05
22.35
17.05
Operating Profit (PBDIT)
340.89
-20.35
-454.80
-298.29
-408.28
-469.22
-312.66
Interest
18.39
22.01
53.25
63.52
59.95
30.67
33.71
Exceptional Items
-7.84
-418.85
-127.32
-7.79
-45.10
-183.44
-4.00
Gross Profit (PBDT)
1,545.16
1,048.60
751.16
566.82
449.81
323.40
265.98
Depreciation
53.89
58.89
54.60
49.34
39.74
30.55
12.24
Profit Before Tax
260.77
-520.10
-689.96
-418.95
-553.07
-713.88
-362.61
Tax
25.54
15.88
13.53
-0.17
1.06
1.20
-0.69
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
235.24
-535.98
-703.49
-418.78
-554.13
-715.08
-361.92
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
235.24
-535.98
-703.49
-418.78
-554.13
-715.08
-361.92
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
235.24
-535.98
-703.49
-418.78
-554.13
-715.08
-361.92
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
1,527.74
859.34
384.95
928.01
761.76
818.19
1,032.28
Earnings per share (EPS)
2.34
-5.8
-8.03
-5.15
-7.11
-9.71
-5.46
Diluted Earnings per share
2.34
-5.8
-8.03
-5.15
-7.11
-9.71
-5.46
Operating Profit Margin (Excl OI)
11.47%
-21.54%
-56.83%
-64.0%
-104.44%
-137.1%
-113.59%
Gross Profit Margin
16.54%
-37.09%
-68.1%
-52.66%
-95.04%
-179.43%
-116.39%
PAT Margin
12.37%
-43.11%
-75.4%
-59.66%
-102.6%
-187.77%
-120.22%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2024 is 52.98% vs 33.26% in Dec 2023
Consolidate Net Profit
YoY Growth in year ended Dec 2024 is 143.88% vs 23.81% in Dec 2023
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2024 is 230.21% vs 56.08% in Dec 2023
Interest
YoY Growth in year ended Dec 2024 is -16.36% vs -58.65% in Dec 2023
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2024 has improved from Dec 2023
Compare Annual Results Of Sarepta Therapeutics, Inc. With
Figures in Million
Consolidate Annual Results
Change(USD)
Change(%)
Net Sales
1,901.98
2,263.58
-361.60
-15.97%
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,901.98
2,263.58
-361.60
-15.97%
Raw Material Cost
356.82
0.00
356.82
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
238.33
0.00
238.33
Power Cost
0
0
0.00
Manufacturing Expenses
18.39
225.51
-207.12
-91.85%
Selling and Distribution Expenses
548.60
236.67
311.93
131.80%
Other Expenses
52.18
-22.35
74.53
333.47%
Total Expenditure (Excl Depreciation)
1,683.90
238.67
1,445.23
605.53%
Operating Profit (PBDIT) excl Other Income
218.08
2,024.90
-1,806.82
-89.23%
Other Income
68.92
75.43
-6.51
-8.63%
Operating Profit (PBDIT)
340.89
1,367.87
-1,026.98
-75.08%
Interest
18.39
225.51
-207.12
-91.85%
Exceptional Items
-7.84
188.46
-196.30
-104.16%
Gross Profit (PBDT)
1,545.16
0.00
1,545.16
Depreciation
53.89
0.00
53.89
Profit Before Tax
260.77
1,330.81
-1,070.04
-80.41%
Tax
25.54
0.00
25.54
Provisions and contingencies
0
0
0.00
Profit After Tax
235.24
858.98
-623.74
-72.61%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
235.24
858.98
-623.74
-72.61%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
471.83
-471.83
-100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
235.24
1,330.81
-1,095.57
-82.32%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
1,527.74
6,946.58
-5,418.84
-78.01%
Earnings per share (EPS)
2.34
1.91
0.43
22.51%
Diluted Earnings per share
2.34
1.91
0.43
22.51%
Operating Profit Margin (Excl OI)
11.47%
57.10%
0.00
-45.63%
Gross Profit Margin
16.54%
58.79%
0.00
-42.25%
PAT Margin
12.37%
37.95%
0.00
-25.58%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 190.20 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 52.98% vs 33.26% in Dec 2023
Annual - Consolidate Net Profit
Consolidate Net Profit 23.52 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 143.88% vs 23.81% in Dec 2023
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 27.20 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 230.21% vs 56.08% in Dec 2023
Annual - Interest
Interest 1.84 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is -16.36% vs -58.65% in Dec 2023
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 11.47%
in Dec 2024Figures in %
YoY Growth in year ended Dec 2024 has improved from Dec 2023
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
